miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.
about
Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST]MYC and the art of microRNA maintenanceThe new concepts on overcoming drug resistance in lung cancer.MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers.KITLG is a novel target of miR-34c that is associated with the inhibition of growth and invasion in colorectal cancer cells.MicroRNA-34c expression in donor cells influences the early development of somatic cell nuclear transfer bovine embryosMicroRNA-124 suppresses the transactivation of nuclear factor of activated T cells by targeting multiple genes and inhibits the proliferation of pulmonary artery smooth muscle cellsGenome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencingUp-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer.Post-transcriptional controls by ribonucleoprotein complexes in the acquisition of drug resistance.MicroRNAs as therapeutic targets in chemoresistance.MicroRNAs-role in lung cancer.Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel.Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway.The role of microRNAs in lung cancer progression.Therapy-induced enrichment of putative lung cancer stem-like cells.Oncogenes associated with drug resistance in ovarian cancer.MicroRNAs: a new key in lung cancer.Tubulin inhibitors in non-small cell lung cancer: looking back and forward.Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222.miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer.Emerging treatment using tubulin inhibitors in advanced non-small cell lung cancer.Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathwaysMiR-34c inhibits osteosarcoma metastasis and chemoresistance.The tumour suppressor miR-34c targets MET in prostate cancer cells.Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.Borealin dimerization mediates optimal CPC checkpoint function by enhancing localization to centromeres and kinetochores.A two-compartment microfluidic device for long-term live cell detection based on surface plasmon resonance.Pri-microRNA-124 rs531564 polymorphism minor allele increases the risk of pulmonary artery hypertension by abnormally enhancing proliferation of pulmonary artery smooth muscle cells.miR-34c works downstream of p53 leading to dairy goat male germline stem-cell (mGSCs) apoptosis.Novel post-transcriptional and post-translational regulation of pro-apoptotic protein BOK and anti-apoptotic protein Mcl-1 determine the fate of breast cancer cells to survive or die.Icariine Restores LPS-Induced Bone Loss by Downregulating miR-34c Level.MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells.Integrated Lung and Tracheal mRNA-Seq and miRNA-Seq Analysis of Dogs with an Avian-Like H5N1 Canine Influenza Virus Infection.Downregulation of SIRT6 by miR-34c-5p is associated with poor prognosis and promotes colon cancer proliferation through inhibiting apoptosis via the JAK2/STAT3 signaling pathway.MicroRNA-520a-5p displays a therapeutic effect upon chronic myelogenous leukemia cells by targeting STAT3 and enhances the anticarcinogenic role of capsaicin.Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells
P2860
Q21133528-1034DE89-461E-4C05-BB22-D748A5F4089EQ26825457-0163C272-0C00-45E9-8F32-760B66323893Q33754114-3A4799EC-4030-420D-A3D8-B6E5D30A7116Q34154782-9EB4559A-7AA2-49F0-B20C-91EB7BA947A3Q34571575-BE766963-7D9E-42CD-A7FD-749F5C798250Q34579327-2CDE3483-B6B0-46BB-B0DD-765ED8729CC4Q34818972-8F8E943B-91F5-4987-A06C-DBAF3A399183Q35075782-AB240B1E-905C-44B6-89ED-8CEE0CE6C2D6Q35405268-19E2112E-E024-497C-8D2F-39128256B294Q35848114-7A13A384-6E02-4FF0-93CC-70637CA97177Q36288519-1699989A-F3BC-4882-ADE5-167B835BC60DQ36530680-DB7E173C-FABB-4F53-9662-41E65CCEA939Q37139289-7161455F-C8CD-4A4E-AA54-3213AF947600Q37381107-02C8F3B6-EB5A-4084-B6BF-6373D293D180Q37679619-91F063BF-09B1-4206-993B-276EE2CD7A86Q37694030-FEBC9A04-4E55-4277-85C8-B6857E501C86Q37734888-F58541C4-F4C2-49D4-B00E-2FC266481EEBQ38127375-5A402B29-C047-447F-B4BC-E525E8C04CE4Q38150766-A3DC64E7-2818-408E-A709-646246894DE8Q38226577-45F8B6FC-9124-4B1E-B1DD-029E54AA8F88Q38241121-FB8EA7D4-994B-4821-BAE0-26779319CA44Q38742506-E285C5A8-2423-4182-9DBD-3FF8150B6242Q38835306-D034804B-6DB4-4026-9009-515465D7B80AQ38845695-28AA9083-7C09-4F95-AF5C-6402B1171E26Q38847914-4BC5146E-0125-4829-AC18-214AFD31731BQ38851326-E1199E36-1B14-464C-AB98-1380F3B93931Q38997836-8EA436FA-0A88-42E9-98EA-CB276F2A2D28Q39114252-0329DC9C-593F-4A67-A8E6-37D309448129Q39191770-9ABFD07C-4C68-47AD-9E10-0BDABFF1FCABQ39480463-7EBD6959-7A34-4082-9BB3-3DC1F3E764D5Q41763755-AEBA8832-059B-4C4A-A26D-6D518B96F3C4Q42179558-278390B0-6841-4FE0-8C4E-0F63C8AB68A7Q43794094-46E6BE0B-B01E-4A6A-B5F7-E19A8D8FF05BQ47168387-A22362F4-E836-43E1-907D-B4CDD1C01864Q50231813-CAB89004-D7B5-4578-84FA-55A28D21BEE3Q51821489-4AE6AD69-151B-40A5-A5EB-F7CDA3752B65Q52647764-F623AADE-2E49-4E30-8310-6C9D17F60721Q52670082-6261525E-D47A-4D0D-BA03-6425BCD539E5Q54206519-73D1A50B-B27D-40D3-916D-80ED7613E7AEQ58549853-DA961F86-0307-418F-8A4C-A5AE17931D2A
P2860
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.
@en
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.
@nl
type
label
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.
@en
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.
@nl
prefLabel
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.
@en
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.
@nl
P2093
P2860
P50
P356
P1433
P1476
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis
@en
P2093
P Pognonec
V de Franciscis
P2860
P2888
P304
P356
10.1038/ONC.2012.51
P407
P577
2012-02-27T00:00:00Z